Basel, 22 December 2017 Roche and Ignyta reach definitive merger agreement Roche to acquire Ignyta for US$ 27.00 per share Ignyta’s investigational medicine entrectinib, a selective CNS-active tyrosine-kinase inhibitor being developed for tumours that harbor ROS1 or NTRK fusions, to expand Roche’s portfolio of oncology medicines Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc.... Read more
Basel, 22 December 2017 Roche and Ignyta reach definitive merger agreement Roche to acquire Ignyta for US$ 27.00 per share Ignyta’s investigational medicine entrectinib, a selective CNS-active tyrosine-kinase inhibitor being developed for tumours that harbor ROS1 or NTRK fusions, to expand Roche’s portfolio of oncology medicines Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc.... Read more
Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership WALTHAM, Mass., Dec. 20, 2017 /PRNewswire/ — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T)... Read more
NEW YORK and BILLERICA, Mass., Dec. 13, 2017 /PRNewswire/ — The Metropolitan Museum of Art (The Met) and Bruker Corporation are pleased to announce a 10-year partnership to advance novel analytical technologies and methods in the field of cultural heritage science even further. This partnership builds upon and expands a long history of collaboration that has... Read more
FRANKLIN LAKES, N.J., Dec. 11, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has established a Product Security Partnership Program that emphasizes collaboration across the health care industry to enhance cybersecurity of medical technology and devices. The new program has three primary components: Participation with... Read more
12.06.17 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced it has been awarded a 10-year fielded contract through the United States Department of Defense’s (DOD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP) omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. 908 Devices is recognized for its patented and award-winning high-pressure mass spectrometry™ (HPMS) technology, which... Read more
WED, DEC 06, 2017 16:00 CET Stockholm – Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) has today entered into an agreement to acquire all outstanding shares in the privately held company Horizon Technology, Inc. (Horizon) based in New Hampshire, US, at a purchase price of approx. USD 18.4 million, corresponding to approx. SEK 153 million[1],... Read more
Download PDF Read more
Thermo Fisher Scientific Acquires Continuous Emission Monitoring Assets from EPTEK Technology WALTHAM, Mass., Dec. 4, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has completed the acquisition of certain assets from EPTEK Technology Co. LTD and several related entities with offices in Taiwan and mainland China. The... Read more
London, UK, Nov 30, 2017 LGC and NuGEN have today announced a collaboration agreement for the commercialisation of the Single Primer Enrichment Technology (SPET) and distribution of Allegro Targeted Genotyping reagents for NGS library preparation. This collaboration will benefit customers of both LGC and NuGEN, as it expands options to access the SPET technology through the SeqSNP service in LGC’s global service... Read more